Status:
COMPLETED
Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream
Lead Sponsor:
LEO Pharma
Conditions:
Atopic Dermatitis
Eligibility:
MALE
18-65 years
Phase:
PHASE1
Brief Summary
The principle aim of this study is to obtain safety, tolerability and pharmacokinetic data when LEO 39652 cream is administered cutaneously as single dose to subjects with atopic dermatitis and to hea...
Eligibility Criteria
Inclusion
- Healthy subjects or subjects with AD as defined by the Hanifen and Rajka criteria and with at least mild disease activity (IGA \>2) for the whole body
- AD lesions amenable to cutaneous treatment located on the trunk and/or limbs (only for AD subjects)
- Male subjects aged between 18 and 65 years with a body mass index (BMI) between 19.0 and 32.0 kg/m2 inclusive
Exclusion
- Subjects who currently suffer from, or show signs of eczema or other skin lesions (only for healthy subjects)
- Subjects who are still participating in a clinical trial (e.g. attending follow-up visits) or who have participated in a clinical study involving administration of an investigational product or a marketed drug product within the past 3 months prior to the first dosing occasion.
- Subjects with known immunocompromised state due to treatment with immunosuppressive drugs or due to history of a disease leading to immunocompromised status.
- History of or current cardiac arrhythmic disorder
- Subjects with a current active malignancy or a history of malignancy in remission for less than 5 years except excised skin (not melanoma) and cervical cancer.
- Subjects who have any clinically significant allergic disease (excluding non- active hayfever) as determined by the Investigator
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT01850849
Start Date
May 1 2013
End Date
December 1 2014
Last Update
February 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Covance Clinical Research Unit, Hyde Street, Leeds, UK
Leeds, United Kingdom, LS2 9LH
2
Covance Royal Liverpool Clinical Research Unit
Liverpool, United Kingdom, L7 8XP